1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > VD in Singapore and Malaysia

VD in Singapore and Malaysia

  • January 2014
  • -
  • Kalorama Information
  • -
  • 200 pages

IVD manufacturers seeking marginal growth are focusing on regional markets. The whole of Southeast Asia represents a unique opportunity for healthcare providers and their various industry suppliers, including the in vitro diagnostics (IVD) industry. In this report, Kalorama details two nations that are expected to provide opportunity for IVD manufacturers: Singapore and Malaysia.

The nexus of regional trade, and a leading port and center for the entire Asia-Pacific, is Singapore. The city-state features the most developed and highest rated healthcare system in Southeast Asia and serves as the headquarters and regional manufacturing center for some medical device, biotechnology, IVD, and pharmaceutical companies. Its neighbor Malaysia, an upper middle-income nation has arguably the second-most developed healthcare system in Southeast Asia. Through Singapore or Kuala Lumpur, IVD companies have access to approximately 35 million potential patients, over 700,000 annual medical tourists, and healthcare systems with higher per capita spending than anywhere else in Southeast Asia or anywhere in Asia outside of Japan, Australia, or Korea. Singapore and Malaysia present IVD markets and opportunities with healthy prospects and solid fundaments in clinical demand.

This Kalorama Information Report, IVD in Singapore and Malaysia contains the following data:

Healthcare Statistics for Singapore and Malaysia
Significant Hospitals in Both Countries
The Lab Market in Singapore and Malaysia
Markets for Key Segments Clinical Chemistry, Microbiology - ID/AST, Microbiology - Molecular, PointofCare - OTC Diabetes, PointofCare - OTC Other, PointofCare- Professional, Immunoassays - Infectious Disease, Immunoassays - Other, Urinalysis, Molecular Diagnostics, Coagulation, Histology, Hematology, Blood Testing and Typing, Flow Cytometry)

Table Of Contents

VD in Singapore and Malaysia

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
MediPoint: Cardiac Markers Rapid Tests and Point of Care - Global Analysis and Market Forecasts

MediPoint: Cardiac Markers Rapid Tests and Point of Care - Global Analysis and Market Forecasts

  • $ 5995
  • Industry report
  • December 2016
  • by GlobalData

MediPoint: Cardiac Markers Rapid Tests and Point of Care - Global Analysis and Market Forecasts Summary Global cardiac marker point-of-care (POC) market to remain a promising area of growth within the ...

Point-of-care Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Point-of-care Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Point-of-Diagnostics Market: Overview Point-of-care diagnostics is carried out in the clinics, home or near patient locations for testing of a sample from a patient in order to facilitate a prompt ...

In Vitro Diagnostics/IVD Market by Product, Technology, Application - Forecast to 2021

In Vitro Diagnostics/IVD Market by Product, Technology, Application - Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global IVD market is projected to reach USD 78.74 billion by 2021, at a CAGR of 5.5% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the increasing prevalence ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.